Granulomatous interstitial nephritis secondary to adalimumab therapy

Tumour necrosis factor α (TNF-α) inhibitors are frequently used for the treatment of immune-mediated diseases. Conversely, cytokine therapy has the potential to paradoxically induce autoimmunity. A number of case reports have emerged concerning sarcoid-like granulomatosis secondary to TNF-α therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandys, Vicki, Moloney, Brona, Lane, Louise, Qazi, Junaid, Doyle, Brendan, Barry, Maurice, Leavey, Sean, Conlon, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Tubulointerstitial Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887274/
https://www.ncbi.nlm.nih.gov/pubmed/29644062
http://dx.doi.org/10.1093/ckj/sfx104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887274/
https://www.ncbi.nlm.nih.gov/pubmed/29644062
http://dx.doi.org/10.1093/ckj/sfx104

Ejemplares similares